Dietary modulation of gut microbiota for the relief of irritable bowel syndrome

키워드

참고문헌 (140)

1. Sperber AD, "Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study", Gastroenterology, 160, pp.99~114 (2021)
2. Drossman DA, "Functional gastrointestinal disorders : history, pathophysiology, clinical features and Rome IV", Gastroenterology, 150, pp.1262~1279 (2016)
3. Lacy BE, "Bowel disorders", Gastroenterology, 150, pp.1393.E5~1407.E5 (2016)
4. Pimentel M, "Rifaximin therapy for patients with irritable bowel syndrome without constipation", N Engl J Med, 364, pp.22~32 (2011)
5. Lembo A, "Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome", Gastroenterology, 151, pp.1113~1121 (2016)
6. Ponziani FR, "Eubiotic properties of rifaximin : disruption of the traditional concepts in gut microbiota modulation", World J Gastroenterol, 23, pp.4491~4499 (2017)
7. Mazzawi T, "The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation", PLoS One, 13, pp.e0194904~ (2018)
8. Soderholm AT, "Intestinal epithelial cells : at the interface of the microbiota and mucosal immunity", Immunology, 158, pp.267~280 (2019)
9. Mowat AM, "Regional specialization within the intestinal immune system", Nat Rev Immunol, 14, pp.667~685 (2014)
10. Sutheera Ratanasirintrawoot, "Stem Cells in the Intestine: Possible Roles in Pathogenesis of Irritable Bowel Syndrome", Journal of Neurogastroenterology and Motility (JNM), 22(3), pp.367~382 (2016), 대한소화기 기능성질환∙운동학회[DOI]
11. O'Hara AM, "The gut flora as a forgotten organ", EMBO Rep, 7, pp.688~693 (2006)
12. Li M, "Role of dendritic cell-mediated abnormal immune response in visceral hypersensitivity", Int J Clin Exp Med, 8, pp.13243~13250 (2015)
13. Zhou C, "Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation", Gut Microbes, 12, pp.1782156~ (2020)
14. Vincent AD, "Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin", Am J Physiol Gastrointest Liver Physiol., 315, pp.G896~G907 (2018)
15. Geremia A, "Innate and adaptive immunity in inflammatory bowel disease", Autoimmun Rev, 13, pp.3~10 (2014)
16. Eshraghian A, "Interstitial cells of Cajal : a novel hypothesis for the pathophysiology of irritable bowel syndrome", Can J Gastroenterol, 25, pp.277~279 (2011)
17. El-Salhy M, "The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome", Expert Rev Gastroenterol Hepatol, 11, pp.139~148 (2017)
18. Chong PP, "The microbiome and irritable bowel syndrome-A review on the pathophysiology, current research and future therapy", Front Microbiol, 10, pp.1136~ (2019)
19. Davenport ER, "The human microbiome in evolution", BMC Biol, 15, pp.127~ (2017)
20. Scarpellini E, "The human gut microbiota and virome : potential therapeutic implications", Dig Liver Dis, 47, pp.1007~1012 (2015)
21. Turnbaugh PJ, "The human microbiome project", Nature, 449, pp.804~810 (2007)
22. Rinninella E, "What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases", Microorganisms, 7, pp.14~ (2019)
23. Jeffery IB, "An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota", Gut, 61, pp.997~1006 (2012)
24. Dominguez-Bello MG, "Development of the human gastrointestinal microbiota and insights from high-throughput sequencing", Gastroenterology, 140, pp.1713~1719 (2011)
25. Conlon MA, "The impact of diet and lifestyle on gut microbiota and human health", Nutrients, 7, pp.17~44 (2014)
26. Simrén M, "Intestinal microbiota in functional bowel disorders : a Rome foundation report", Gut, 62, pp.159~176 (2013)
27. Tuddenham S, "The intestinal microbiome and health", Curr Opin Infect Dis, 28, pp.464~470 (2015)
28. Duncan SH, "The role of pH in determining the species composition of the human colonic microbiota", Environ Microbiol, 11, pp.2112~2122 (2009)
29. Nicholson JK, "Host-gut microbiota metabolic interactions", Science, 336, pp.1262~1267 (2012)
30. Quigley EM, "The gut-brain axis and the microbiome : clues to pathophysiology and opportunities for novel management strategies in irritable bowel syndrome(IBS)", J Clin Med, 7, pp.6~ (2018)
31. van de Wouw M, "Microbiota-gut-brain axis : modulator of host metabolism and appetite", J Nutr, 147, pp.727~745 (2017)
32. Fung C, "Functional circuits and signal processing in the enteric nervous system", Cell Mol Life Sci, 77, pp.4505~4522 (2020)
33. Bhattarai Y, "Irritable bowel syndrome: a gut microbiota-related disorder?", Am J Physiol Gastrointest Liver Physiol., 312, pp.G52~G62 (2017)
34. Agus A, "Gut microbiota regulation of tryptophan metabolism in health and disease", Cell Host Microbe, 23, pp.716~724 (2018)
35. Gao K, "Tryptophan metabolism : a link between the gut microbiota and brain", Adv Nutr, 11, pp.709~723 (2020)
36. Yano JM, "Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis", Cell, 161, pp.264~276 (2015)
37. De Vadder F, "Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks", Proc Natl Acad Sci U S A, 115, pp.6458~6463 (2018)
38. Berstad A, "Tryptophan : ‘essential’ for the pathogenesis of irritable bowel syndrome?", Scand J Gastroenterol, 49, pp.1493~1498 (2014)
39. Bosi A, "Tryptophan metabolites along the microbiota-gut-brain axis : an interkingdom communication system influencing the gut in health and disease", Int J Tryptophan Res, 13, pp.1178646920928984~ (2020)
40. Zelante T, "Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22", Immunity, 39, pp.372~385 (2013)
41. O'Mahony SM, "Serotonin, tryptophan metabolism and the brain-gut-microbiome axis", Behav Brain Res, 277, pp.32~48 (2015)
42. Williams BB, "Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine", Cell Host Microbe, 16, pp.495~503 (2014)
43. Levy M, "Dysbiosis and the immune system", Nat Rev Immunol, 17, pp.219~232 (2017)
44. Petersen C, "Defining dysbiosis and its influence on host immunity and disease", Cell Microbiol, 16, pp.1024~1033 (2014)
45. Bellini M, "Irritable bowel syndrome : a disease still searching for pathogenesis, diagnosis and therapy", World J Gastroenterol, 20, pp.8807~8820 (2014)
46. Tap J, "Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome", Gastroenterology, 152, pp.111~123 (2017)
47. Schmidt TS, "The human gut microbiome : from association to modulation", Cell, 172, pp.1198~1215 (2018)
48. Hyland NP, "Microbe-host interactions : influence of the gut microbiota on the enteric nervous system", Dev Biol, 417, pp.182~187 (2016)
49. Pittayanon R, "Gut microbiota in patients with irritable bowel syndrome-A systematic review", Gastroenterology, 157, pp.97~108 (2019)
50. Rodiño-Janeiro BK, "A Review of microbiota and irritable bowel syndrome : future in therapies", Adv Ther, 35, pp.289~310 (2018)
51. Le Chatelier E, "Richness of human gut microbiome correlates with metabolic markers", Nature, 500, pp.541~546 (2013)
52. Merino VR, "Quantitative detection of enterotoxigenic Bacteroides fragilis subtypes isolated from children with and without diarrhea", J Clin Microbiol, 49, pp.416~418 (2011)
53. Distrutti E, "Gut microbiota role in irritable bowel syndrome : new therapeutic strategies", World J Gastroenterol, 22, pp.2219~2241 (2016)
54. David LA, "Diet rapidly and reproducibly alters the human gut microbiome", Nature, 505, pp.559~563 (2014)
55. Muegge BD, "Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans", Science, 332, pp.970~974 (2011)
56. Chey WD, "Food : the main course to wellness and illness in patients with irritable bowel syndrome", Am J Gastroenterol, 111, pp.366~371 (2016)
57. Chey WD, "Dietary guidelines for irritable bowel syndrome are important for gastroenterologists, dietitians and people with irritable bowel syndrome", J Hum Nutr Diet, 29, pp.547~548 (2016)
58. Human Microbiome Project Consortium, "Structure, function and diversity of the healthy human microbiome", Nature, 486, pp.207~214 (2012)
59. Conlon MA, "Lowering of large bowel butyrate levels in healthy populations is unlikely to be beneficial", J Nutr, 145, pp.1030~1031 (2015)
60. Madsen KL, "Interactions between microbes and the gut epithelium", J Clin Gastroenterol., 45(Suppl), pp.S111~S114 (2011)
61. Thursby E, "Introduction to the human gut microbiota", Biochem J, 474, pp.1823~1836 (2017)
62. McKenzie YA, "British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults(2016 update)", J Hum Nutr Diet, 29, pp.549~575 (2016)
63. Halmos EP, "Diets that differ in their FODMAP content alter the colonic luminal microenvironment", Gut, 64, pp.93~100 (2015)
64. Holscher HD, "Dietary fiber and prebiotics and the gastrointestinal microbiota", Gut Microbes, 8, pp.172~184 (2017)
65. Ma N, "Contributions of the interaction between dietary protein and gut microbiota to intestinal health", Curr Protein Pept Sci, 18, pp.795~808 (2017)
66. Singh RK, "Influence of diet on the gut microbiome and implications for human health", J Transl Med, 15, pp.73~ (2017)
67. Tuck CJ, "Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions", Neurogastroenterol Motil, 30, pp.e13238~ (2018)
68. Didari T, "Effectiveness of probiotics in irritable bowel syndrome : updated systematic review with meta-analysis", World J Gastroenterol, 21, pp.3072~3084 (2015)
69. Grabitske HA, "Low-digestible carbohydrates in practice", J Am Diet Assoc, 108, pp.1677~1681 (2008)
70. Murray K, "Differential effects of FODMAPs(fermentable oligo-, di-, mono-saccharides and polyols)on small and large intestinal contents in healthy subjects shown by MRI", Am J Gastroenterol, 109, pp.110~119 (2014)
71. Mayer EA, "Brain-gut microbiome interactions and functional bowel disorders", Gastroenterology, 146, pp.1500~1512 (2014)
72. Macfarlane GT, "Bacteria, colonic fermentation, and gastrointestinal health", J AOAC Int, 95, pp.50~60 (2012)
73. Farup PG, "Faecal short-chain fatty acids-a diagnostic biomarker for irritable bowel syndrome?", BMC Gastroenterol, 16, pp.51~ (2016)
74. Tana C, "Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome", Neurogastroenterol Motil, 22, pp.512~519 (2010)
75. El-Salhy M, "Dietary fiber in irritable bowel syndrome(Review)", Int J Mol Med, 40, pp.607~613 (2017)
76. Clevers E, "Adherence to diet low in fermentable carbohydrates and traditional diet for irritable bowel syndrome", Nutrition, 73, pp.110719~ (2020)
77. Rajilić-Stojanović M, "Intestinal microbiota and diet in IBS : causes, consequences, or epiphenomena?", Am J Gastroenterol, 110, pp.278~287 (2015)
78. Muir JG, "The low FODMAP diet for treatment of irritable bowel syndrome and other gastrointestinal disorders", Gastroenterol Hepatol(N Y), 9, pp.450~452 (2013)
79. Shepherd SJ, "Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome : randomized placebo-controlled evidence", Clin Gastroenterol Hepatol, 6, pp.765~771 (2008)
80. De Giorgio R, "Sensitivity to wheat, gluten and FODMAPs in IBS : facts or fiction?", Gut, 65, pp.169~178 (2016)
81. Shepherd SJ, "Short-chain carbohydrates and functional gastrointestinal disorders", Am J Gastroenterol, 108, pp.707~717 (2013)
82. McIntosh K, "FODMAPs alter symptoms and the metabolome of patients with IBS : a randomised controlled trial", Gut, 66, pp.1241~1251 (2017)
83. Halmos EP, "A diet low in FODMAPs reduces symptoms of irritable bowel syndrome", Gastroenterology, 146, pp.67.e5~75.e5 (2014)
84. Austin GL, "A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome", Clin Gastroenterol Hepatol, 7, pp.706.e1~708.e1 (2009)
85. Shepherd SJ, "Fructose malabsorption and symptoms of irritable bowel syndrome : guidelines for effective dietary management", J Am Diet Assoc, 106, pp.1631~1639 (2006)
86. Marsh A, "Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis", Eur J Nutr, 55, pp.897~906 (2016)
87. Staudacher HM, "The low FODMAP diet : recent advances in understanding its mechanisms and efficacy in IBS", Gut, 66, pp.1517~1527 (2017)
88. Varjú P, "Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: a meta-analysis of clinical studies", PLoS One, 12, pp.e0182942~ (2017)
89. Dionne J, "A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome", Am J Gastroenterol, 113, pp.1290~1300 (2018)
90. Hustoft TN, "Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome", Neurogastroenterol Motil, 29, pp.e12969~ (2017)
91. Bellini M, "Low FODMAP diet : evidence, doubts, and hopes", Nutrients, 12, pp.148~ (2020)
92. Staudacher HM, "Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome", J Nutr, 142, pp.1510~1518 (2012)
93. Staudacher HM, "Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet : probiotics, prebiotics and the low FODMAP diet", Proc Nutr Soc, 75, pp.306~318 (2016)
94. Chumpitazi BP, "Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome", Gut Microbes, 5, pp.165~175 (2014)
95. Chumpitazi BP, "Randomised clinical trial : gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome", Aliment Pharmacol Ther, 42, pp.418~427 (2015)
96. Daïen CI, "Detrimental impact of microbiota-accessible carbohydrate-deprived diet on gut and immune homeostasis : an overview", Front Immunol, 8, pp.548~ (2017)
97. Chadwick VS, "Activation of the mucosal immune system in irritable bowel syndrome", Gastroenterology, 122, pp.1778~1783 (2002)
98. O'Sullivan M, "Increased mast cells in the irritable bowel syndrome", Neurogastroenterol Motil, 12, pp.449~457 (2000)
99. Barbara G, "Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome", Gastroenterology, 126, pp.693~702 (2004)
100. Akiho H, "Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome", World J Gastrointest Pathophysiol, 1, pp.97~105 (2010)
101. Sinagra E, "Inflammation in irritable bowel syndrome : myth or new treatment target?", World J Gastroenterol, 22, pp.2242~2255 (2016)
102. El-Salhy M, "Diet in irritable bowel syndrome", Nutr J, 14, pp.36~ (2015)
103. Shivappa N, "Designing and developing a literature-derived, population-based dietary inflammatory index", Public Health Nutr, 17, pp.1689~1696 (2014)
104. Buscail C, "Western dietary pattern is associated with irritable bowel syndrome in the French NutriNet Cohort", Nutrients, 9, pp.986~ (2017)
105. Khayyatzadeh SS, "Dietary patterns and prevalence of irritable bowel syndrome in Iranian adults", Neurogastroenterol Motil, 28, pp.1921~1933 (2016)
106. Calder PC, "Dietary factors and low-grade inflammation in relation to overweight and obesity", Br J Nutr., 106(Suppl 3), pp.S5~S78 (2011)
107. Galland L, "Diet and inflammation", Nutr Clin Pract, 25, pp.634~640 (2010)
108. Menotti A, "How the seven countries study contributed to the definition and development of the Mediterranean diet concept : a 50-year journey", Nutr Metab Cardiovasc Dis, 25, pp.245~252 (2015)
109. Hidalgo-Mora JJ, "The Mediterranean diet : a historical perspective on food for health", Maturitas, 132, pp.65~69 (2020)
110. Trichopoulou A, "Definitions and potential health benefits of the Mediterranean diet : views from experts around the world", BMC Med, 12, pp.112~ (2014)
111. Estruch R, "Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts", N Engl J Med., 378, pp.e34~ (2018)
112. Gambino CM, "Effect of extra virgin olive oil and table olives on the immuneinflammatory responses : potential clinical applications", Endocr Metab Immune Disord Drug Targets, 18, pp.14~22 (2018)
113. Deiana M, "Modulation of intestinal epithelium homeostasis by extra virgin olive oil phenolic compounds", Food Funct, 9, pp.4085~4099 (2018)
114. Farràs M, "Modulation of the gut microbiota by olive oil phenolic compounds : implications for lipid metabolism, immune system, and obesity", Nutrients, 12, pp.2200~ (2020)
115. Salas-Salvadó J, "The effect of nuts on inflammation", Asia Pac J Clin Nutr., 17(Suppl 1), pp.333~336 (2008)
116. Holscher HD, "Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults : a randomized controlled trial", J Nutr, 148, pp.861~867 (2018)
117. Bamberger C, "A walnut-enriched diet affects gut microbiome in healthy caucasian subjects : a randomized, controlled trial", Nutrients, 10, pp.244~ (2018)
118. Zito FP, "Good adherence to mediterranean diet can prevent gastrointestinal symptoms : a survey from Southern Italy", World J Gastrointest Pharmacol Ther, 7, pp.564~571 (2016)
119. Shin PK, "A traditional Korean diet with a low dietary inflammatory index increases anti-inflammatory IL-10 and decreases pro-inflammatory NF-κB in a small dietary intervention study", Nutrients, 12, pp.2468~ (2020)
120. Barbalho SM, "Irritable bowel syndrome : a review of the general aspects and the potential role of vitamin D", Expert Rev Gastroenterol Hepatol, 13, pp.345~359 (2019)
121. Jalili M, "Effects of vitamin D supplementation in patients with irritable bowel syndrome : a randomized, double-blind, placebo-controlled clinical trial", Int J Prev Med, 10, pp.16~ (2019)
122. Khalighi Sikaroudi M, "Vitamin D3 supplementation in diarrhea-predominant irritable bowel syndrome patients : the effects on symptoms improvement, serum corticotropin-releasing hormone, and interleukin-6-A randomized clinical trial", Complement Med Res, 27, pp.302~309 (2020)
123. Khalighi Sikaroudi M, "Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin(5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA", 5-HT in patients with diarrhea-predominant irritable bowel syndrome : a randomized clinical trial, 2020, pp.19, 652~667
124. Shi SM, "Effectiveness of vitamin D for irritable bowel syndrome: a protocol for a systematic review of randomized controlled trial", Medicine (Baltimore), 98, pp.e14723~ (2019)
125. Ligaarden SC, "Low intake of vitamin B6 is associated with irritable bowel syndrome symptoms", Nutr Res, 31, pp.356~361 (2011)
126. Salari-Moghaddam A, "Empirically derived food-based inflammatory potential of the diet, irritable bowel syndrome, and its severity", Nutrition, 63-64, pp.141~147 (2019)
127. Zheng J, "Dietary inflammatory potential in relation to the gut microbiome : results from a cross-sectional study", Br J Nutr, 124, pp.931~942 (2020)
128. De Filippis F, "High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome", Gut, 65, pp.1812~1821 (2016)
129. Cozma-Petruţ A, "Diet in irritable bowel syndrome : What to recommend, not what to forbid to patients!", World J Gastroenterol, 23, pp.3771~3783 (2017)
130. Just S, "The gut microbiota drives the impact of bile acids and fat source in diet on mouse metabolism", Microbiome, 6, pp.134~ (2018)
131. Abulizi N, "Gut mucosal proteins and bacteriome are shaped by the saturation index of dietary lipids", Nutrients, 11, pp.418~ (2019)
132. Shen W, "Intestinal and systemic inflammatory responses are positively associated with sulfidogenic bacteria abundance in high-fat-fed male C57BL", 6J mice, 2014, pp.144, 1181~1187
133. Muralidharan J, "Plant-based fat, dietary patterns rich in vegetable fat and gut microbiota modulation", Front Nutr, 6, pp.157~ (2019)
134. Patrone V, "Differential effects of coconut versus soy oil on gut microbiota composition and predicted metabolic function in adult mice", BMC Genomics, 19, pp.808~ (2018)
135. Bailey MA, "Microbiome-mediated effects of the Mediterranean diet on inflammation", Adv Nutr, 9, pp.193~206 (2018)
136. Mani V, "Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia", Nutr Metab(Lond), 10, pp.6~ (2013)
137. Ford AC, "Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation : systematic review and meta-analysis", Am J Gastroenterol, 109, pp.1547~1561 (2014)
138. Wilson B, "Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults : a systematic review and meta-analysis of randomized controlled trials", Am J Clin Nutr, 109, pp.1098~1111 (2019)
139. Staudacher HM, "A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species : a randomized controlled trial", Gastroenterology, 153, pp.936~947 (2017)
140. Staudacher HM, "Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics", Clin Nutr, 40, pp.1861~1870 (2021)

관련 논문AI추천